Hannah M Linden (Hannah Linden)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum

Computed Tomography

Breast Cancer Risk

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Breast cancer research : BCR

Clinical cancer research : an official journal of the American Association for Cancer Research

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Nicole C Loroña, Megan K D Othus, Kathleen E Malone, Hannah M Linden, Mei-Tzu C Tang, Christopher I Li
Alcohol, smoking, and risks of breast cancer recurrence and mortality among women with luminal, triple-negative, and HER2-overexpressing breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Hannah M Linden, David A Mankoff
Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kristine Doney, Wendy M Leisenring, Hannah M Linden
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer. Breast cancer research and treatment 194 (3) (2022)
Perrin E Romine, Lanell M Peterson, Brenda F Kurland, Darrin W Byrd, Alena Novakova-Jiresova, Mark Muzi, Jennifer M Specht, Robert K Doot, Jeanne M Link, Kenneth A Krohn, Paul E Kinahan, David A Mankoff, Hannah M Linden
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study. Breast cancer research : BCR 23 (1) (2021)
Jean A McDougall, Linda S Cook, Mei-Tzu C Tang, Hannah M Linden, Beti Thompson, Christopher I Li
Determinants of Guideline-Discordant Breast Cancer Care. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (1) (2020)